Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors ; volume:15 ; number:1 ; day:3 ; month:9 ; year:2015 ; pages:1-19 ; date:12.2015
BMC cancer ; 15, Heft 1 (3.9.2015), 1-19, 12.2015
- Urheber
-
Devarakonda, Charan V.
- Beteiligte Personen und Organisationen
-
Kita, Daniel
Phoenix, Kathryn N.
Claffey, Kevin P.
SpringerLink (Online service)
- DOI
-
10.1186/s12885-015-1608-z
- URN
-
urn:nbn:de:1111-2016110619435
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Devarakonda, Charan V.
- Kita, Daniel
- Phoenix, Kathryn N.
- Claffey, Kevin P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Characterization of single chain antibody targets through yeast two hybrid
HSP90-stabilized proteins as therapeutic targets in cancer
Widespread amyloidogenicity potential of multiple myeloma patient-derived immunoglobulin light chains
Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
Molecular mechanisms of antibody light chain amyloidogenicity
Molecular Insights into Antibody Light Chain Pathogenicity
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia
HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation
Phosphoregulation des Hsp90-Chaperonsystems
Hsp90 depletion goes wild
Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis
Characterization of single chain antibody targets through yeast two hybrid
HSP90-stabilized proteins as therapeutic targets in cancer
Widespread amyloidogenicity potential of multiple myeloma patient-derived immunoglobulin light chains
Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
Molecular mechanisms of antibody light chain amyloidogenicity
Molecular Insights into Antibody Light Chain Pathogenicity
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia
HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation
Phosphoregulation des Hsp90-Chaperonsystems
Hsp90 depletion goes wild
Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis
Characterization of single chain antibody targets through yeast two hybrid
HSP90-stabilized proteins as therapeutic targets in cancer
Widespread amyloidogenicity potential of multiple myeloma patient-derived immunoglobulin light chains
Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
Molecular mechanisms of antibody light chain amyloidogenicity
Molecular Insights into Antibody Light Chain Pathogenicity
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia
HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation
Phosphoregulation des Hsp90-Chaperonsystems
Hsp90 depletion goes wild